Pharmaceutical biotechnology
Curr Opin Biotechnol
.
1995 Dec 1;6(6):621-3.
doi: 10.1016/0958-1669(95)80102-2.
Authors
F McCormick
1
,
W Wierenga
Affiliation
1
Frank McCormick, Onyx Pharmaceuticals, 3031 Research Drive, Building A, Richmond, California 94806, USA.Wendell Wierenga, Parke-Davis Pharmaceutical Division, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105-2430, USA.
PMID:
8791304
DOI:
10.1016/0958-1669(95)80102-2
No abstract available